| Identification | |
| Name: | Guanosine,2'-deoxy-6-thio- |
| Synonyms: | 9H-Purine-6(1H)-thione,2-amino-9-(2-deoxy-b-D-erythro-pentofuranosyl)- (7CI,8CI); 2-Amino-9-(2-deoxy-b-D-erythro-pentofuranosyl)-6-mercaptopurine;2'-Deoxy-6-thioguanosine; 2'-Deoxythioguanosine; 2'-Desoxy-6-thioguanosine; NSC71261; TGdR; Thioguanine deoxyriboside; b-Thioguanine deoxyriboside |
| CAS: | 789-61-7 |
| Molecular Formula: | C10H13 N5 O3 S |
| Molecular Weight: | 283.34 |
| InChI: | InChI=1/C10H13N5O3S/c11-10-13-8-7(9(19)14-10)12-3-15(8)6-1-4(17)5(2-16)18-6/h3-6,16-17H,1-2H2,(H3,11,13,14,19)/t4-,5+,6+/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 382.6°C |
| Boiling Point: | 709.1°C at 760 mmHg |
| Density: | 2.02g/cm3 |
| Refractive index: | 1.93 |
| Specification: |
The extinguishing agent of Thioguanine deoxyriboside (CAS No.789-61-7) are dry powder, foam, sand, carbon dioxide, water mist. |
| Report: |
NCI Carcinogenesis Bioassay (ipr). clear evidence: rat, NCITR* National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD 20014) No. NCI-TR-57 ,1978. ; NCI Carcinogenesis Bioassay (ipr). inadequate studies:mouse, NCITR* National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD 20014) No. NCI-TR-57 ,1978. |
| Flash Point: | 382.6°C |
| Usage: | Guanosine (G837900) derivative with cancer chemotherapeutic properties. It is involved in the inhibition of human RNase H-mediated RNA cleavage from DNA-RNA duplexes via incorporation into DNA. |
| Safety Data | |
| Hazard Symbols | |
 |
|
